COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Quick-Clot powder could save lives in severe trauma bleeding
Disease control Recruiting nowThis study compares two treatments to help blood clot in severely injured trauma patients with major bleeding. One is a standard frozen blood product (cryoprecipitate) that takes time to thaw, and the other is a dry powder (fibrinogen concentrate) that can be given at the bedside…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated May 03, 2026 08:11 UTC
-
New drug hopes to tame deadly sepsis clotting in ICU patients
Disease control Recruiting nowThis early-stage study tests a new drug called BAY 3389934 in 36 ICU patients with sepsis-induced coagulopathy, a condition where the body's response to infection causes dangerous blood clots. The main goal is to check the drug's safety and find the right dose. Participants will …
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 03, 2026 08:10 UTC
-
New blood test for kids: will it measure up?
Knowledge-focused Recruiting nowThis study is testing a device called TEG 6s that measures how well blood clots. Researchers want to see if it gives accurate results in healthy children under 18 who are having planned surgery. About 125 kids will give a small blood sample at the start of their operation. The go…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 03, 2026 08:09 UTC